Edition:
United States

China Biologic Products Holdings Inc (CBPO.OQ)

CBPO.OQ on NASDAQ Stock Exchange Global Select Market

80.06USD
20 Oct 2017
Change (% chg)

$3.31 (+4.31%)
Prev Close
$76.75
Open
$77.19
Day's High
$80.06
Day's Low
$76.27
Volume
201,688
Avg. Vol
101,169
52-wk High
$125.99
52-wk Low
$76.27

Latest Key Developments (Source: Significant Developments)

China Biologic agrees to acquire Tianxinfu from PWM
Thursday, 12 Oct 2017 08:30am EDT 

Oct 12 (Reuters) - China Biologic Products Holdings Inc :China Biologic agrees to acquire Tianxinfu from PWM.China Biologic Products Holdings Inc - ‍It has agreed to acquire 80% equity interest in Tianxinfu (Beijing) Medical Appliance Co., Ltd​.China Biologic Products - ‍In exchange for acquisition of 80% equity interest in Tianxinfu from PWM, Cbpo will issue 5.5 million ordinary shares to PWM​.China Biologic Products - ‍PWM is expected to hold approximately 16.66% of outstanding share capital of Cbpo taking into effect new issuance​ post deal.China Biologic Products - Board determined to exempt deal from causing PWM to be deemed "acquiring person" under CBPO's preferred shares rights agreement​.China Biologic Products Holdings Inc - ‍Acquire 80% equity interest in Tianxinfu from PW Medtech Group Limited​.China Biologic Products - ‍CBPO elected to be exempted from shareholder approval requirement under applicable rules of nasdaq market for proposed deal.China Biologic Products Holdings - ‍Elected to be exempted from shareholder approval requirement under applicable rules of Nasdaq stock market for deal.China Biologic Products Holdings Inc - ‍Post deal close, PWM expected to hold about 16.66% of share capital of co taking into effect new issuance​.  Full Article

China Biologic receives approval for commercial manufacturing of human fibrinogen
Monday, 9 Oct 2017 08:30am EDT 

Oct 9 (Reuters) - China Biologic Products Holdings Inc :China Biologic receives approval for commercial manufacturing of human fibrinogen.China Biologic Products Holdings Inc - ‍expects first batch of products to be released to market by end of 2017​.China Biologic Products Holdings Inc - ‍expect to see meaningful profit contribution from fibrinogen in 2018​.China Biologic Products Holdings - unit received approval from China food and drug administration for commercial manufacturing of human fibrinogen.  Full Article

China Biologic reports Q1 earnings per share $1.06
Wednesday, 3 May 2017 04:45pm EDT 

May 3 (Reuters) - China Biologic Products Inc :China Biologic reports financial results for the first quarter of 2017.Q1 adjusted non-GAAP earnings per share $1.32.Q1 earnings per share $1.06.Sees FY 2017 sales up 13 to 15 percent.Q1 sales rose 6.9 percent to $91.5 million.China Biologic Products Inc -Reiterates full year financial forecast.China Biologic Products Inc says inventories increased by $9.1 million in Q1 of 2017.  Full Article

China Biologic reports Q1 earnings per share $1.06
Wednesday, 3 May 2017 04:45pm EDT 

May 3 (Reuters) - China Biologic Products Inc :China Biologic reports financial results for the first quarter of 2017.Q1 adjusted non-GAAP earnings per share $1.32.Q1 earnings per share $1.06.Sees FY 2017 sales up 13 to 15 percent.Q1 sales rose 6.9 percent to $91.5 million.China Biologic Products Inc -Reiterates full year financial forecast.China Biologic Products Inc says inventories increased by $9.1 million in Q1 of 2017.  Full Article

China Biologic Q4 adjusted non-GAAP earnings per share $0.95
Thursday, 23 Feb 2017 05:00pm EST 

China Biologic Products Inc : China Biologic reports financial results for the fourth quarter and fiscal year 2016 . Q4 adjusted non-GAAP earnings per share $0.95 . Q4 earnings per share $0.69 . Q4 sales rose 13.6 percent to $77.6 million . China Biologic Products says expects total sales to grow 13% to 15% in RMB terms for 2017 .China Biologic Products Inc sees 2017 non-GAAP adjusted net income to grow 18% to 20% in RMB terms.  Full Article

China Biologic Q4 adjusted non-GAAP earnings per share $0.95
Thursday, 23 Feb 2017 05:00pm EST 

China Biologic Products Inc : China Biologic reports financial results for the fourth quarter and fiscal year 2016 . Q4 adjusted non-GAAP earnings per share $0.95 . Q4 earnings per share $0.69 . Q4 sales rose 13.6 percent to $77.6 million . China Biologic Products says expects total sales to grow 13% to 15% in RMB terms for 2017 .China Biologic Products Inc sees 2017 non-GAAP adjusted net income to grow 18% to 20% in RMB terms.  Full Article

Baillie Gifford & Co reports 5.21 pct passive stake in China Biologic Products
Friday, 13 Jan 2017 09:04am EST 

China Biologic Products Inc :Baillie Gifford & Co reports 5.21 percent passive stake in China Biologic Products Inc as of december 31 - sec filing.  Full Article

Baillie Gifford & Co reports 5.21 pct passive stake in China Biologic Products
Friday, 13 Jan 2017 09:04am EST 

China Biologic Products Inc :Baillie Gifford & Co reports 5.21 percent passive stake in China Biologic Products Inc as of december 31 - sec filing.  Full Article

China Biologic Products says reiterates its full year forecast of total sales growth
Wednesday, 4 Jan 2017 08:30am EST 

China Biologic Products Inc : China Biologic Products says reiterates its full year forecast of total sales growth of 22 pct to 24 pct in rmb terms . China Biologic Products says reiterates its full year forecast of non-GAAP adjusted net income growth of 33 pct to 35 pct in rmb terms .China Biologic Products sees total sales,non-GAAP adjusted net income in USD terms in 2016 will be adversely affected by foreign currency translation impact.  Full Article

China Biologic Products says reiterates its full year forecast of total sales growth
Wednesday, 4 Jan 2017 08:30am EST 

China Biologic Products Inc : China Biologic Products says reiterates its full year forecast of total sales growth of 22 pct to 24 pct in rmb terms . China Biologic Products says reiterates its full year forecast of non-GAAP adjusted net income growth of 33 pct to 35 pct in rmb terms .China Biologic Products sees total sales,non-GAAP adjusted net income in USD terms in 2016 will be adversely affected by foreign currency translation impact.  Full Article

BRIEF-China Biologic agrees to acquire Tianxinfu from PWM

* China Biologic Products Holdings Inc - ‍It has agreed to acquire 80% equity interest in Tianxinfu (Beijing) Medical Appliance Co., Ltd​